Privia Health Group (NASDAQ:PRVA) Given New $40.00 Price Target at Piper Sandler

Privia Health Group (NASDAQ:PRVA) had its target price raised by Piper Sandler from $25.00 to $40.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Piper Sandler’s price objective would suggest a potential upside of 57.11% from the stock’s previous close.

Other research analysts have also recently issued reports about the stock. JMP Securities reissued a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Friday, February 14th. Needham & Company LLC raised their price objective on Privia Health Group from $25.00 to $30.00 and gave the stock a “buy” rating in a research note on Friday. Truist Financial raised their price target on Privia Health Group from $24.00 to $27.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Barclays raised their target price on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Finally, JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a research report on Friday, November 29th. One equities research analyst has rated the stock with a hold rating, fifteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $26.35.

Privia Health Group Trading Up 5.8 %

NASDAQ:PRVA opened at $25.46 on Friday. The firm’s fifty day simple moving average is $22.30 and its 200 day simple moving average is $20.55. Privia Health Group has a twelve month low of $15.92 and a twelve month high of $26.04. The firm has a market capitalization of $3.06 billion, a price-to-earnings ratio of 254.63, a PEG ratio of 3.47 and a beta of 0.87.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Quadrant Capital Group LLC lifted its position in shares of Privia Health Group by 11.8% during the 4th quarter. Quadrant Capital Group LLC now owns 4,855 shares of the company’s stock valued at $95,000 after acquiring an additional 511 shares during the last quarter. Park Avenue Securities LLC grew its holdings in shares of Privia Health Group by 3.8% during the fourth quarter. Park Avenue Securities LLC now owns 14,697 shares of the company’s stock valued at $287,000 after buying an additional 532 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Privia Health Group by 8.0% during the fourth quarter. PNC Financial Services Group Inc. now owns 7,169 shares of the company’s stock valued at $140,000 after buying an additional 533 shares during the period. First Horizon Advisors Inc. lifted its stake in Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares in the last quarter. Finally, Summit Investment Advisors Inc. boosted its position in Privia Health Group by 6.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 10,673 shares of the company’s stock worth $209,000 after acquiring an additional 678 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.